|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Retrospective analysis of extra-gastrointestinal stromal tumors显示文摘AIM:To investigate the clinicopathologic features of patients with extra-gastrointestinal stromal tumors(EGISTs)in South Korea.METHODS:A total of 51 patients with an EGIST were identified.The clinicopathologic features,including sex,age,location,tumor size,histology,mitotic rate,immunohistochemical features,genetic status and survival data,were analyzed.RESULTS:The median age was 55 years(range:29-80years),and male:female ratio was 1:1.04.The most common site was in the mesentery(n=15)followed by the retroperitoneum(n=13)and omentum(n=8).The median tumor size was 9.0 cm(range:2.6-30.0cm)and the median mitotic rate was 5.0/50HPF.(1/50-185/50).KIT was analyzed in 16,which revealed 10cases with wild-type KIT and 6 cases with an exon 11mutation.Among 51 patients,31 patients had undergone surgery,and 10 had unresectable disease and had taken palliative imatinib,which resulted in 22.7 mo of progression-free survival.Of the patients who had undergone surgery,18 did not take adjuvant imatinib,and 8 of these were categorized as'high risk'according to the risk criteria.However,the relapse-free survival was not different(P=0.157)between two groups.CONCLUSION:Because the biologic behaviors of GISTs differ according to the location of the tumor,a more stratified strategy is required for managing EGISTs including incorporation of molecular features. | Jun Ho Yi Byeong-Bae Park Jung Hun Kang In Gyu Hwang Dong Bok Shin Sun Jin Sym Hee Kyung Ahn Soon Il Lee Do Hyoung Lim Keon Woo Park Young-Woong Won Sung Hee Lim Se Hoon Park | 2015 | World Journal of Gastroenterology2015,21,6: | 9 |
| 2 | Efficacy of a Metallic Stent Covered with a Paclitaxel-Incorporated Membrane Versus a Covered Metal Stent for Malignant Biliary Obstruction: A Prospective Comparative Study显示文摘 | Sung Ill Jang Jie-Hyun Kim Jung Whan You Kwangwon Rhee Se Joon Lee Ho Gak Kim Jimin Han Im Hee Shin Sang-Heum Park Dong Ki Lee | 2013 | Digestive Diseases and Sciences2013,,3: | 2 |
| 3 | 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的Ⅱ期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11)显示文摘背景与目的一项比较艾日布林联合吉西他滨(eribulin plus gemcitabine,EG)或紫杉醇联合吉西他滨(paclitaxel plus gemcitabine,PG)作为转移性乳腺癌(metastatic breast cancer,MBC)患者一线化疗方案的II期临床试验发现,EG方案的神经毒性较低,但疗效与PG方案相似。在本研究中,我们分析了该临床实验中的癌症患者生命质量测评量表–紫杉烷(functional assessment of cancer therapy-taxane,FACT-Taxane)问卷评分以确定他们的生活质量(quality of life,QoL)。方法使用韩国版的FACT-Taxane问卷评估QoL。在评估基线之后,前12个疗程中每2个疗程评估1次QoL,之后每3个疗程评估1次QoL。使用线性混合模型评估EG组和PG组QoL的差异。结果在118例入组患者中,117例在基线时回复了FACT-Taxane问卷,PG组中有1例患者没有回复。EG组和PG组之间的基线QoL评分没有差异。在治疗期间,除了第11个疗程外,在第2–13个化疗疗程后,PG组紫杉烷亚量表评分显著高于EG组(均P<0.05)。神经病变特异性分析显示PG组患者的神经病症状比EG组患者更早出现且更严重(P<0.001)。结论在我们的QoL分析中,与PG方案相比,EG方案延迟并减少神经病变的发生。因此,艾日布林是MBC一线化疗药物紫杉醇的合理替代品。 | Ji‑Yeon Kim Seri Park Seock‑Ah Im Sung‑Bae Kim Joohyuk Sohn Keun Seok Lee Yee Soo Chae Ki Hyeong Lee Jee Hyun Kim Young‑Hyuck Im Tae‑Yong Kim Kyung‑Hun Lee Jin‑Hee Ahn Gun Min Kim In Hae Park Soo Jung Lee Hye Sook Han Se Hyun Kim Kyung Hae Jung Yeon Hee Park Korean Cancer Study Group | 2019 | 癌症2019,38,8: | 2 |
| 4 | Incremental Predictive Value of Red Cell Distribution Width for 12‐Month Clinical Outcome After Acute Myocardial Infarction显示文摘 | Jang Hoon Lee Dong Heon Yang Se Yong Jang Won Suk Choi Kyun Hee Kim Won Kee Lee Myung Hwan Bae Hun Sik Park Yongkeun Cho Shung Chull Chae | 2013 | Clin Cardiol2013,,6: | 2 |
| 5 | Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice显示文摘 | Se Jin Park Younghwa Lee Hee Kyong Oh Hyung Eun Lee Younghwan Lee Sang Yoon Ko Boseong Kim Jae Hoon Cheong Chan Young Shin Jong Hoon Ryu | 2014 | Neuropharmacology2014,,: | 2 |
| 6 | Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma显示文摘AIM: To assess the efficacy and safety of weekly docetaxel plus a fixed-dose rate(FDR) of gemcitabine in metastatic esophageal squamous cell carcinoma(SCC).METHODS: A multi-center, open-label, prospective phase Ⅱ study was designed.Thirty-three esophageal SCC patients with documented progression after fluoropyrimidine/platinum-based first-line chemotherapy were enrolled and treated with docetaxel 35 mg/m2 and gemcitabine 1000 mg/m2 iv at a FDR(10 mg/m2 per minute) on days 1 and 8.Treatment was repeatedevery twenty-one days until disease progression, unacceptable toxicity, or consent withdrawal.The primary endpoint was response rate(RR), and secondary endpoints were safety, progression-free survival(PFS) and overall survival(OS).RESULTS: Combination of weekly docetaxel and FDR gemcitabine was well tolerated: the most common treatment-related adverse events were anemia(97%), fatigue(64%) and neutropenia(55%).One patient with multiple lung and lymph node metastases died of respiratory failure after receiving four cycles of chemotherapy, and the possibility of drug-induced pneumonitis could not be completely excluded.Disease control(objective response plus stable disease) in the ITT population was achieved in 88% of patients, and the overall RR was 30%(95%CI: 15%-46%).The median PFS and OS were 4.0(95%CI: 3.4-4.6) and 8.8 mo(95%CI: 7.8-9.8 mo), respectively.CONCLUSION: A combination of weekly docetaxel and FDR gemcitabine showed promising antitumor activity and tolerability in previously treated, metastatic esophageal SCC. | Min-Young Lee Ki Sun Jung Hae Su Kim Ji Yun Lee Sung Hee Lim Moonjin Kim Hyun Ae Jung Sung Min Kim Jong Mu Sun Myung-Ju Ahn Jeeyun Lee Se Hoon Park Seong Yoon Yi In Gyu Hwang Sang-Cheol Lee Hee Kyung Ahn Do Hyoung Lim Soon Il Lee Keon Woo Park | 2015 | World Journal of Gastroenterology2015,21,14: | 2 |
| 7 | Diversity of Rotavirus Strain Circulated in Gwangju, Republic of Korea显示文摘 | Min Ji Kim Hye Sook Jeong Seon Gyeong Kim Se Mi Lee Sun Hee Kim Hye-Young Kee Eun-hye Jo Hye-jung Park Dong-Ryong Ha Eun Sun Kim Kye-Won Seo Jae Keun Chung | 2014 | Osong Public Health and Research Perspectives2014,,: | 1 |
| 8 | Metatranscriptomic analysis of lactic acid bacterial gene expression during kimchi fermentation显示文摘 | Jung Ji Young Lee Se Hee Jin Hyun Mi | 2013 | International Journal of Food Microbiology2013,163,: | 1 |
| 9 | Low grade chondrosarcoma of the nasal septum显示文摘Chondrosarcoma of the nasal septum is extremely rare. In some cases, it may be diff icult to preoperatively differentiate low grade chondrosarcoma from benign cartilaginous tumors such as chondroma. We report a case of low grade chondrosarcoma of the nasal septum with characteristic radiologic f indings. Characteristic radiologic f indings such as calcif ications on computed tomography scan and a ring-and-arc pattern on enhanced T1 weighted image were useful in the preoperative diagnosis of low grade chondrosarcoma of the septum. Awareness of radiologic f indings of low grade chondrosarcoma can help to make an accurate diagnosis and perform appropriate excision, leading to successful local control. | Dong Hoon Lee Se Hee Jung Tae Mi Yoon Joon Kyoo Lee Young Eun Joo Sang Chul Lim | 2013 | World Journal of Clinical Cases2013,1,1: | 1 |
| 10 | Perforation in colorectal stenting: a meta-analysis and a search for risk factors显示文摘 | Emo E. van Halsema Jeanin E. van Hooft Aaron J. Small Todd H. Baron Jesús García-Cano Jae Hee Cheon Moon Sung Lee Se Hwan Kwon Stéphanie Mucci-Hennekinne Paul Fockens Marcel G.W. Dijkgraaf Alessandro Repici | 2013 | Gastrointestinal Endoscopy2013,,: | 1 |
| 11 | Expression of Maspin in Colon Cancers: Its Relationship with p53 Expression and Microvessel Density显示文摘 | Sang Yong Song Se Kyung Lee Duck Hwan Kim Hee Jung Son Hong Joo Kim Yun Jeong Lim Woo Yong Lee Ho-Kyung Chun Jong Chul Rhee | 2002 | Digestive Diseases and Sciences2002,,8: | 1 |
| 12 | Conformal Coatings of Cyclized‐PAN for Mechanically Resilient Si nano‐Composite Anodes显示文摘 | Daniela Molina Piper Thomas A. Yersak Seoung‐Bum Son Seul Cham Kim Chan Soon Kang Kyu Hwan Oh Chunmei Ban Anne C. Dillon Se‐Hee Lee | 2013 | Adv. Energy Mater2013,,6: | 1 |
| 13 | Chylothorax Complicating Pulmonary Resection for Lung Cancer: Effective Management and Pleurodesis显示文摘 | Hyun Jin Cho Dong Kwan Kim Geun Dong Lee Hee Je Sim Se Hoon Choi Hyeong Ryul Kim Yong-Hee Kim Seung-Il Park | 2013 | The Annals of Thoracic Surgery2013,,: | 1 |
| 14 | Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer显示文摘 | Hyo Song Kim Seong Yoon Yi Hyun Jung Jun Jeeyun Lee Se Hoon Park Jong Kyun Lee Kyu Taek Lee Kwang Hyuck Lee Dong Wook Choi Seong-Ho Choi Jin Seok Heo Young Suk Park Ho Yeong Lim Won Ki Kang Hee Chul Park Do Hoon Lim Joon Oh Park | 2010 | Anti-Cancer Drugs2010,,1: | 1 |
| 15 | Lymphoepithelial cyst of the pancreas: comparison of CT findings with other pancreatic cystic lesions显示文摘 | Won Hwa Kim Jae Young Lee Hee Sun Park Hyung Jin Won Young Hun Kim Jin Young Choi Se Hyung Kim Joon Koo Han Byung Ihn Choi | 2013 | Abdominal Imaging2013,,2: | 1 |
| 16 | Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data显示文摘BACKGROUND Neuropathy is a common chronic complication in type 2 diabetes mellitus(T2DM).Statin and metformin are commonly used medications in T2DM patients,and some studies showed statin-or metformin-induced neuropathy.AIM To evaluate the incidence of neuropathy among patients with T2DM associated with statin and metformin therapies.METHODS Korean Health Insurance Review and Assessment national patient sample data from 2016 and 2017 were used.Patients with T2DM and no complications were divided into statin/metformin/statin+metformin users and non-users.Neuropathy incidence was defined by International Statistical Classification of Diseases and Related Health Problems,10th revision codes and concomitant prescriptions for anticonvulsants or antidepressants.Logistic regression analyses were conducted to examine the associations between statin/metformin/statin+metformin therapies and the incidence of neuropathy.Propensity score(PS)matching was performed on the basis of age,sex and comorbidities.RESULTS Overall,34964 and 35887 patients with T2DM and no complications were included in the Korean Health Insurance Review and Assessment national patient sample datasets from 2016 and 2017,respectively.Statin therapy was associated with increased risks of neuropathy in 2016 and 2017[PS-matched odds ratio(OR)=1.22,95%confidence interval(CI):1.08-1.38;PS-matched OR=1.17,95%CI:1.03-1.33,respectively].Metformin therapy was associated with reduced risks of neuropathy in 2016 and 2017(PS-matched OR=0.30,95%CI:0.21-0.42;PSmatched OR=0.44,95%CI:0.32-0.60,respectively).Combined statin+metformin therapy was not significantly associated with neuropathy in 2016 or 2017(PSmatched OR=0.85,95%CI:0.61-1.19;PS-matched OR=0.95,95%CI:0.66-1.38,respectively).CONCLUSION Statin therapy was associated with enhanced risk of new-onset neuropathy in patients with T2DM,but metformin therapy showed the opposite association. | Hong Ki Min Se Hee Kim Jong Han Choi Kyomin Choi Hae-Rim Kim Sang-Heon Lee | 2021 | World Journal of Clinical Cases2021,9,33: | 1 |
| 17 | Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy显示文摘 | Jeeyun Lee Yeon Hee Park Won Seog Kim Seung-Sook Lee Baek-Yeol Ryoo Sung Hyun Yang Keon Woo Park Jung Hoon Kang Joon Oh Park Se Hoon Lee Kihyun Kim Chul Won Jung Young Suk Park Young-Hyuck Im Won Ki Kang Mark H. Lee Young H. Ko Yong Chan Ahn Keunchil Park | 2005 | European Journal of Cancer2005,,10: | 1 |
| 18 | A simple model to predict bacteremia in women with acute pyelonephritis显示文摘 | Kyung Su Kim Kyuseok Kim You Hwan Jo Tae Yun Kim Jin Hee Lee Se Jong Lee Joong Eui Rhee Gil Joon Suh | 2011 | Journal of Infection2011,,: | 1 |
| 19 | Quality of life outcomes including neuropathy-associated scale from a phase II,multicenter,randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer:Korean Cancer Study Group Trial(KCSG BR13-11)显示文摘Background: A phase II clinical trial of the comparison between eribulin plus gemcitabine (EG) and paclitaxel plus gemcitabine (PG) as first-line chemotherapy for patients with metastatic breast cancer (MBC) found that the EG regimen was less neurotoxic, but was similar in efficacy to the PG regimen. In the present study, we analyzed functional assessment of cancer therapy-taxane (FACT-Taxane) questionnaires from patients in this clinical trial to determine their quality of life (QoL). Methods: QoL was assessed using the Korean version of the FACT-Taxane questionnaires. After baseline assessment, QoL was assessed every 2 cycles for 12 cycles and every 3 cycles thereafter. The linear mixed model was used to evaluate the difference in QoL between the EG and PG arms. Results: Of the 118 enrolled patients, 117 responded to the FACT-Taxane questionnaires at baseline, 1 in the PG arm did not. Baseline QoL scores were not different between the EG and PG arms. During treatment, taxane subscale scores were significantly higher in the PG arm than in the EG arm after 2-13 cycles of chemotherapy (all P < 0.05), except for the 11th cycle. Neuropathy-specific analysis showed that patients in the PG arm had earlier and more severe neuropathic symptoms than those in the EG arm (P < 0.001). Conclusions: In our QoL analysis, the EG regimen delayed and decreased neuropathy as compared with the PG regimen. Therefore, eribulin would be a reasonable substitute for paclitaxel as first-line chemotherapy for MBC. | Ji-Yeon Kim Seri Park Seock-Ah Im Sung-Bae Kim Joohyuk Sohn Keun Seok Lee Yee Soo Chae Ki Hyeong Lee Jee Hyun Kim Young-Hyuck Im Tae-Yong Kim Kyung-Hun Lee Jin-Hee Ahn Gun Min Kim In Hae Park Soo Jung Lee Hye Sook Han Se Hyun Kim Kyung Hae Jung Yeon Hee Park Korean Cancer Study Group | 2019 | Cancer Communications2019,39,1: | 1 |
| 20 | Kimchi microflora: history, current status, and perspectives for industrial kimchi production显示文摘 | Ji Young Jung Se Hee Lee Che Ok Jeon | 2014 | Applied Microbiology and Biotechnology2014,,6: | 1 |